中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 5
May  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(5): 1144-1149

Histopathological characteristics of the liver in children with non-alcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2023.05.021
  • a.

    Department of Pathology, Hunan Children's Hospital, Changsha 410000, China

  • b.

    Liver Disease Center, Hunan Children's Hospital, Changsha 410000, China

Research funding:

Research Project Plan of Hunan Provincial Health Commission (202206014267)

More Information
  • Corresponding author: LI Shuangjie, 2273858951@qq.com(ORCID: 0000-0002-3792-6793)
  • Received Date: 2022-09-02
  • Accepted Date: 2022-11-09
  • Published Date: 2023-05-20
    Abstract
    • FullText(HTML)
  • loading
    • References(34)
  • [1]
    YOUNOSSI Z, ANSTEE QM, MARIETTI M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(1): 11-20. DOI: 10.1038/nrgastro.2017.109.
    [2]
    ZHANG YP, ZHU YB, YAO Y, et al. Association of high-fructose high-salt diet with metabolic syndrome[J]. J Clin Exp Med, 2022, 21(15): 1569-1572. DOI: 10.3969/j.issn.1671-4695.2022.15.001.

    张雅娉, 朱耀斌, 高琰, 等. 高果糖高盐饮食与代谢综合征的关系研究[J]. 临床和实验医学杂志, 2022, 21(15): 1569-1572. DOI: 10.3969/j.issn.1671-4695.2022.15.001.
    [3]
    ESTES C, ANSTEE QM, ARIAS-LOSTE MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69(4): 896-904. DOI: 10.1016/j.jhep.2018.05.036.
    [4]
    ESLAM M, NEWSOME PN, SARIN SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209. DOI: 10.1016/j.jhep.2020.03.039.
    [5]
    XIAO QQ, WANG MY, FAN JG. Brief introduction of APASL clinical practice guidelines on metabolic associated fatty liver disease(Treatment Part)[J]. J Clin Hepatol, 2021, 37(1): 41-45. DOI: 10.3696/j.issn.1001-5256.2021.01.009.

    肖倩倩, 王梦雨, 范建高. 亚太肝病研究学会代谢相关脂肪性肝病临床诊疗指南(治疗部分)简介[J]. 临床肝胆病杂志, 2021, 37(1): 41-45. DOI: 10.3696/j.issn.1001-5256.2021.01.009.
    [6]
    OZTURK Y, SOYLU OB. Fatty liver in childhood[J]. World J Hepatol, 2014, 6(1): 33-40. DOI: 10.4254/wjh.v6.i1.33.
    [7]
    SIMON TG, ROELSTRAETE B, HARTJES K, et al. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality[J]. J Hepatol, 2021, 75(5): 1034-1041. DOI: 10.1016/j.jhep.2021.06.034.
    [8]
    Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. J Clin Hepatol, 2019, 35(10): 2163-2172. DOI: 10.3969/j.issn.1001-5256.2019.10.007.

    中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年)[J]. 临床肝胆病杂志, 2019, 35(10): 2163-2172. DOI: 10.3969/j.issn.1001-5256.2019.10.007.
    [9]
    VOS MB, ABRAMS SH, BARLOW SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)[J]. J Pediatr Gastroenterol Nutr, 2017, 64(2): 319-334. DOI: 10.1097/MPG.0000000000001482.
    [10]
    KLEINER DE, BRUNT EM, VAN NATTA M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6): 1313-1321. DOI: 10.1002/hep.20701.
    [11]
    SCHWIMMER JB, BEHLING C, NEWBURY R, et al. Histopathology of pediatric nonalcoholic fatty liver disease[J]. Hepatology, 2005, 42(3): 641-649. DOI: 10.1002/hep.20842.
    [12]
    KLEINER DE, BRUNT EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research[J]. Semin Liver Dis, 2012, 32(1): 3-13. DOI: 10.1055/s-0032-1306421.
    [13]
    ANDERSON EL, HOWE LD, JONES HE, et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis[J]. PLoS One, 2015, 10(10): e0140908. DOI: 10.1371/journal.pone.0140908.
    [14]
    DISTEFANO JK. NAFLD and NASH in postmenopausal women: Implications for diagnosis and treatment[J]. Endocrinology, 2020, 161(10): bqaa134. DOI: 10.1210/endocr/bqaa134.
    [15]
    WEIHE P, WEIHRAUCH-BLVHER S. Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives[J]. Curr Obes Rep, 2019, 8(4): 472-479. DOI: 10.1007/s13679-019-00357-x.
    [16]
    WANG CE, XU WT, GONG J, et al. Treatment of patients with nonalcoholic fatty liver disease[J]. Clin J Med Offic, 2022, 50(9): 897-899, 903. DOI: 10.16680/j.1671-3826.2022.09.06.

    王彩娥, 许文涛, 宫建, 等. 非酒精性脂肪性肝病治疗研究进展[J]. 临床军医杂志, 2022, 50(9): 897-899, 903. DOI: 10.16680/j.1671-3826.2022.09.06.
    [17]
    MANCO M, MARCELLINI M, DEVITO R, et al. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis[J]. Int J Obes (Lond), 2008, 32(2): 381-387. DOI: 10.1038/sj.ijo.0803711.
    [18]
    DOYCHEVA I, WATT KD, ALKHOURI N. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic[J]. Hepatology, 2017, 65(6): 2100-2109. DOI: 10.1002/hep.29068.
    [19]
    GUO ZQ, WANG QY, QI XS, et al. Recommendations for the diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases (2017)[J]. J Clin Hepatol, 2017, 33(12): 2275-2277. DOI: 10.3969/j.issn.1001-5256.2017.12.003.

    郭泽淇, 王倩怡, 祁兴顺, 等. 《2017年美国肝病学会非酒精性脂肪性肝病诊疗指导》摘译[J]. 临床肝胆病杂志, 2017, 33(12): 2275-2277. DOI: 10.3969/j.issn.1001-5256.2017.12.003.
    [20]
    KLEINER DE, MAKHLOUF HR. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children[J]. Clin Liver Dis, 2016, 20(2): 293-312. DOI: 10.1016/j.cld.2015.10.011.
    [21]
    SEKI S, KITADA T, YAMADA T, et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases[J]. J Hepatol, 2002, 37(1): 56-62. DOI: 10.1016/s0168-8278(02)00073-9.
    [22]
    CHALASANI N, WILSON L, KLEINER DE, et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease[J]. J Hepatol, 2008, 48(5): 829-834. DOI: 10.1016/j.jhep.2008.01.016.
    [23]
    WANG K, SUN C, DONG C, et al. Analysis of de novo non-alcoholic fatty liver disease in early period after pediatric liver transplantation: a report of 8 cases[J]. Chin J Organ Transplant, 2021, 42(9): 534-538. DOI: 10.3760/cma.j.cn421203-20200728-00261.

    王凯, 孙超, 董冲, 等. 儿童肝移植术后早期新发非酒精性脂肪性肝病八例临床分析[J]. 中华器官移植杂志, 2021, 42(9): 534-538. DOI: 10.3760/cma.j.cn421203-20200728-00261.
    [24]
    WANG XY, WANG LF. Pathological diagnosis of nonalcoholic steatohepatitis[J]. J Prac Hepatol, 2013, 16(6): 486-489. DOI: 10.3969/j.issn.1672-5069.2013.06.003.

    王晓颖, 王立峰. 非酒精性脂肪性肝炎的病理学诊断[J]. 实用肝脏病杂志, 2013, 16(6): 486-489. DOI: 10.3969/j.issn.1672-5069.2013.06.003.
    [25]
    TAKAHASHI Y, INUI A, FUJISAWA T, et al. Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases[J]. Hepatol Res, 2011, 41(11): 1066-1074. DOI: 10.1111/j.1872-034X.2011.00855.x.
    [26]
    SKOIEN R, RICHARDSON MM, JONSSON JR, et al. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways[J]. Liver Int, 2013, 33(4): 624-632. DOI: 10.1111/liv.12100.
    [27]
    CARTER-KENT C, YERIAN LM, BRUNT EM, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study[J]. Hepatology, 2009, 50(4): 1113-1120. DOI: 10.1002/hep.23133.
    [28]
    SINGH S, ALLEN AM, WANG Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies[J]. Clin Gastroenterol Hepatol, 2015, 13(4): 643-654. e1-e9; quiz e39-e40. DOI: 10.1016/j.cgh.2014.04.014.
    [29]
    KANWAR P, KOWDLEY KV. The metabolic syndrome and its influence on nonalcoholic steatohepatitis[J]. Clin Liver Dis, 2016, 20(2): 225-243. DOI: 10.1016/j.cld.2015.10.002.
    [30]
    WANG LM, ZHANG HF, DONG Y, et al. Clinical and pathological characteristics of nonalcoholic steatohepatitis in children[J]. Chin J Pract Pediatr, 2014, 29(12): 932-935. DOI: 10.7504/ek2014120612.

    王丽旻, 张鸿飞, 董漪, 等. 儿童非酒精性脂肪性肝炎临床与病理特点分析[J]. 中国实用儿科杂志, 2014, 29(12): 932-935. DOI: 10.7504/ek2014120612.
    [31]
    ZHU HH, ZHENG RD, MENG JR, et al. Pathological characteristics of nonalcoholic fatty liver disease[J]. Chin Hepatol, 2007, 12(1): 10-12. DOI: 10.14000/j.cnki.issn.1008-1704.2007.01.005.

    朱皓皞, 郑瑞丹, 孟加榕, 等. 非酒精性脂肪性肝病的病理特点分析[J]. 肝脏, 2007, 12(1): 10-12. DOI: 10.14000/j.cnki.issn.1008-1704.2007.01.005.
    [32]
    ZHOU XL, FU JF. Expert consensus on diagnosis and treatment of nonalcoholic fatty liver disease in children[J]. Chin J Pract Pediatr, 2018, 33(7): 487-492. DOI: 10.19538/j.ek2018070602.

    周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识[J]. 中国实用儿科杂志, 2018, 33(7): 487-492. DOI: 10.19538/j.ek2018070602.
    [33]
    PATTON HM, LAVINE JE, van NATTA ML, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis[J]. Gastroenterology, 2008, 135(6): 1961-1971. e2. DOI: 10.1053/j.gastro.2008.08.050.
    [34]
    ABDELMALEK MF, SUZUKI A, GUY C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease[J]. Hepatology, 2010, 51(6): 1961-1971. DOI: 10.1002/hep.23535.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (236) PDF downloads(46) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return